.jpg&contenttype=jpeg)
Bone Support study is underway
Cerament Spine Support, designed by the medical technology company BoneSupport to treat osteoporotic vertebral compression fractures, has achieved full patient enrolment in an open, multi-centre study which will investigate the product’s efficacy, safety, and the beneficial quality of life outcome for the patients.
The study, being carried out at six centres in Germany, involves 40 patients aged between 50-90 years (average: 70 years).
‘In Europe, osteoporotic vertebral fractures are mostly treated in a conservative manner, i.e. painkillers and rest. This lack of curative treatment often ends up in a chronic pain syndrome, a crippling kyphosis, and an inability of the elderly patient to handle her daily situation,’ said Fredrik Lindberg, CEO of BoneSupport. ‘We are delighted to have achieved this important milestone in line with our plan. It should allow us to have the final report published by Q2, 2007,’ he predicted.
Since its establishment in 1999, BoneSupport AB, based in Lund, Sweden, has focused on developing synthetic ceramic, injectable bone substitute materials and associated mixing and injection devices. The firm reports that its unique products are based on patented technology, and are primarily for the treatment of vertebral fractures and osteoporosis.
This article was published on 11/14/2006